Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice

OBJECTIVE: Atherosclerosis is a chronic inflammatory and immune vascular disease, and clinical and experimental evidence has indicated an important role of complement activation products, including the terminal membrane attack complex (MAC), in atherogenesis. Here, we investigated whether complement...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Atherosclerosis
Main Authors: Liu, Fengming, Wu, Lin, Wu, Gongxiong, Wang, Chun, Zhang, Lining, Tomlinson, Stephen, Qin, Xuebin
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4267679/
https://ncbi.nlm.nih.gov/pubmed/24685815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atherosclerosis.2014.03.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados